Article

Tailored Viral-Like Particles as Drivers of Medical Breakthroughs

2024-04-12

Abstract excerpt

Despite the recognized potential of nanoparticles, only a few formulations have progressed to clinical trials, and an even smaller number have been approved by the regulatory authorities and marketed. Virus-like particles (VLPs) have emerged as promising alternatives to most explored nanoparticles because of the absence of viral genetic material, their incapacity to replicate, mimicry of viral structure, and tropi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: bdd6f8db-a833-528a-b75e-500b09d3b137
DOI: 10.20944/preprints202404.0840.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Tailored Viral-Like Particles as Drivers of Medical BreakthroughsDOI 10.20944/preprints202404.0840.v1Read

Recent Progress on the Versatility of Virus-Like ParticlesSemantic proximity Read

Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriersSemantic proximity Read

Rational Design of Virus-like Particles for NanomedicineSemantic proximity Read

Viral nanoparticles and virus‐like particles: platforms for contemporary vaccine designSemantic proximity Read

Virus-Like Particle Nanocarriers for Precision ChemotherapySemantic proximity Read

Virus-like particles: flexible platforms for vaccine developmentSemantic proximity Read

Virus‐like particles as powerful vaccination strategy against human virusesSemantic proximity Read

The coming of age of virus-like particle vaccinesSemantic proximity Read

Developments in virus-like particle-based vaccines for infectious diseases and cancerSemantic proximity Read

Platforms, advances, and technical challenges in virus-like particles-based vaccinesSemantic proximity Read

Bacteriophage lambda: The path from biology to theranostic agentSemantic proximity Read

Virus-like particle-based human vaccines: quality assessment based on structural and functional propertiesSemantic proximity Read